Abstract:BACKGROUNDThis study was aimed at establishing a sensitive and specific isolation, characterization, and enumeration method for living circulating tumor cells (CTCs) in patients with colorectal carcinoma. METHODSQuantitative isolation and characterization of CTCs were performed through a combination of immunomagnetic negative enrichment and fluorescence-activated cell sorting. Isolated CTCs were identified by immunofluorescence staining. The viability and purity of the sorted cells were determined by flow cytometry. Blood samples spiked with HCT116 cells (range, 3-250 cells) were used to determine specificity, recovery, and sensitivity. The method was used to enumerate, characterize, and isolate living CTCs in 10 mL of blood from patients with colorectal carcinoma. RESULTSThe average recovery of HCT116 cells was 61% or more at each spiking level, and the correlation coefficient was 0.992. An analysis of samples from all 18 patients with colorectal carcinoma revealed that 94.4% were positive for CTCs with an average of 3324 CTCs per 10 mL of blood and with a diameter of 14 to 20 m (vs 8-12 m for lymphoma). All patients were CD47(+), with only 4.3% to 61.2% being CD44(+). The number of CTCs was well correlated with the patient TNM stage and could be detected in patients at an early cancer stage. The sorted cells could be recultured, and their viability was preserved. CONCLUSIONSThis method provides a novel technique for highly sensitive and specific detection and isolation of CTCs in patients with colorectal carcinoma. This method complements the existing approaches for the de novo functional identification of a wide variety of CTC types. It is likely to help in predicting a patient's disease progression and potentially in selecting the appropriate treatment. Cancer 2015;121:3036-3045. (c) 2015 American Cancer Society.

A Negative Depletion-Enhanced Filtration System for High-Purity Circulating Tumor Cell Enrichment from Whole Blood

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

An Ultra-Thin Silicon Nitride Membrane for Label-Free CTCs Isolation from Whole Blood with Low WBC Residue

A Combined Negative and Positive Enrichment Assay for Cancer Cells Isolation and Purification.

Negative Isolation of Circulating Tumor Cells Using a Microfluidic Platform Integrated with Streptavidin-Functionalized PLGA Nanofibers

Enhanced and High-Purity Enrichment of Circulating Tumor Cells Based on Immunomagnetic Nanospheres

Enhanced Separation Efficiency and Purity of Circulating Tumor Cells Based on the Combined Effects of Double Sheath Fluids and Inertial Focusing

Engineered Red Blood Cells For Capturing Circulating Tumor Cells With High Performance

Dual targeting negative enrichment strategy for highly sensitive and purity detection of CTCs

A novel whole blood purifier for efficient capture and separation of circulating tumor cells

On-chip Circulating Tumor Cells Isolation Based on Membrane Filtration and Immuno-Magnetic Bead Clump Capture

High-throughput rare cell separation from blood samples using steric hindrance and inertial microfluidics.

Fast, Reusable, Cell Uniformly Distributed Membrane Filtration Device for Separation of Circulating Tumor Cells.

Highly Efficient Capture of Circulating Tumor Cells with Low Background Signals by Using Pyramidal Microcavity Array

Cascaded Filter Deterministic Lateral Displacement Microchips for Isolation and Molecular Analysis of Circulating Tumor Cells and Fusion Cells

Enrichment of Circulating Tumor Cells from Whole Blood Using a Microfluidic Device for Sequential Physical and Magnetophoretic Separations

High throughput capture of circulating tumor cells using an integrated microfluidic system.

Design of a Microfluidic Chip for Enrichment of Circulating Tumor Cells

Isolating Rare Cells and Circulating Tumor Cells with High Purity by Sequential eDAR

A Microfluidic Chip Integrated with a High-Density PDMS-based Microfiltration Membrane for Rapid Isolation and Detection of Circulating Tumor Cells.

Hybrid double-spiral microfluidic chip for RBC-lysis-free enrichment of rare cells from whole blood